Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 22 - Issue 5 - May, 2010

Insights

Commentary
Outcome with Retrievable Inferior Vena Cava Filters: Lost in Translation
05/06/2010
Jaime Ghitelman, MD and Lawrence A. Garcia, MD
Jaime Ghitelman, MD and Lawrence A. G...
Venous thromboembolism (VTE) has an incidence of approximately 100 individuals per 100,000 population each year in the United States. 1 The most common presentation of VTE is deep venous thrombosis (DVT) or its more feared complication,...
Venous thromboembolism (VTE) has an incidence of approximately 100 individuals per 100,000 population each year in the United States. 1 The most common presentation of VTE is deep venous thrombosis (DVT) or its more feared complication,...
Venous thromboembolism (VTE) has...
05/06/2010
Journal of Invasive Cardiology
Commentary
Spontaneous Coronary Artery Dissection: Time for a Concerted Effort to Better Understand This Rare Condition
05/06/2010
Angela Hoye, MB ChB, PhD
Angela Hoye, MB ChB, PhD
Spontaneous coronary artery dissection (SCAD) is a challenge for the interventional cardiologist. Not least because it occurs so rarely that even someone with a large clinical practice will only see a small number of cases, and in addition,...
Spontaneous coronary artery dissection (SCAD) is a challenge for the interventional cardiologist. Not least because it occurs so rarely that even someone with a large clinical practice will only see a small number of cases, and in addition,...
Spontaneous coronary artery...
05/06/2010
Journal of Invasive Cardiology
Commentary
Management of Restenosis in Drug-Eluting Stents: Still a Challenge!
05/06/2010
Mohit Gupta, MD, Jigar Kadakia, MD, Matthew J. Budoff, MD
Mohit Gupta, MD, Jigar Kadakia, MD, ...
Drug-eluting stents (DES) are currently implanted in > 3 million patients worldwide undergoing percutaneous coronary intervention (PCI) each year. With better equipment and understanding of the needs of prolonged dual-antiplatelet therapy...
Drug-eluting stents (DES) are currently implanted in > 3 million patients worldwide undergoing percutaneous coronary intervention (PCI) each year. With better equipment and understanding of the needs of prolonged dual-antiplatelet therapy...
Drug-eluting stents (DES) are...
05/06/2010
Journal of Invasive Cardiology
Commentary
Will the Transradial Approach Become the Preferred Approach in Subclavian Artery Stenting?
05/05/2010
Craig Walker, MD
Craig Walker, MD
Subclavian artery stenting is well established in the therapy of subclavian artery stenosis resulting in “subclavian steal,” arm claudication, myocardial ischemia in patients with prior or intended coronary artery bypass utilizing the...
Subclavian artery stenting is well established in the therapy of subclavian artery stenosis resulting in “subclavian steal,” arm claudication, myocardial ischemia in patients with prior or intended coronary artery bypass utilizing the...
Subclavian artery stenting is...
05/05/2010
Journal of Invasive Cardiology

Feature

Original Contribution
Outcomes with Retrievable Inferior Vena Cava Filters
05/06/2010
Muhammad Janjua, MD, Fahad Younas, MD, Irfan Moinuddin, MD, Aaref Badshah, MD, Abhijeet Basoor, MD, Abdo Y. Yaekoub, MD, Fadi Matta, MD, Kiritkumar C. Patel, MD, Jane Liang, MSc, Russell D. Hull, MBBS, MSc, Paul D. Stein, MD
Muhammad Janjua, MD, Fahad Younas, M...
ABSTRACT: This was a retrospective study of 144 patients with retrievable inferior vena cava (IVC) filters inserted 2004–2008 at a community/teaching hospital. The purpose was to evaluate the incidence of complications and the rate and...
ABSTRACT: This was a retrospective study of 144 patients with retrievable inferior vena cava (IVC) filters inserted 2004–2008 at a community/teaching hospital. The purpose was to evaluate the incidence of complications and the rate and...
ABSTRACT: This was a...
05/06/2010
Journal of Invasive Cardiology
Original Contribution
Unprotected Left Main Angioplasty in Nonagenarians: Clinical Characteristics, Procedural Features and Outcome (full title below
05/06/2010
Sofiene Rekik, MD, Jérôme Brunet, MD, Gilles Bayet, MD, François Xavier Hager, MD, Laurent Meille, MD, Jean Michel Quatre, MD, Joël Sainsous, MD
Sofiene Rekik, MD, Jérôme Brunet, ...
Unprotected Left Main Angioplasty in Nonagenarians: Clinical Characteristics, Procedural Features and Outcome: A Case Series Study ABSTRACT: Limited information is available on clinical characteristics and outcomes in very old patients with...
Unprotected Left Main Angioplasty in Nonagenarians: Clinical Characteristics, Procedural Features and Outcome: A Case Series Study ABSTRACT: Limited information is available on clinical characteristics and outcomes in very old patients with...
Unprotected Left Main...
05/06/2010
Journal of Invasive Cardiology
Original Contribution
Spontaneous Coronary Artery Dissection: Aggressive vs. Conservative Therapy
05/06/2010
Behrooz K. Shamloo, MD, Rajesh S. Chintala, MD, Ali Nasur, MD, Mohammad Ghazvini, MD, Parastoo Shariat*, James A. Diggs, MD, Steven N. Singh, MD
Behrooz K. Shamloo, MD, Rajesh S. Ch...
ABSTRACT: Background. Spontaneous coronary artery dissection (SCAD) is a rare condition that commonly presents as an acute coronary event in the younger population, especially in females of childbearing age. Generally, there is no consensus...
ABSTRACT: Background. Spontaneous coronary artery dissection (SCAD) is a rare condition that commonly presents as an acute coronary event in the younger population, especially in females of childbearing age. Generally, there is no consensus...
ABSTRACT: Background. ...
05/06/2010
Journal of Invasive Cardiology
Original Contribution
Longer-Term Outcomes of Paclitaxel Stent Implantation (Full Title Below)
05/06/2010
Justin P. Levisay, MD, Matthew J. Price, MD, Wisam Shaba, MD, Steve S. Lee, MD,Curtiss P. Stinis, MD, Latrice Miller, BA, Paul S. Teirstein, MD
Justin P. Levisay, MD, Matthew J. Pr...
Longer-Term Outcomes of Paclitaxel Stent Implantation as an Initial Treatment Strategy for Sirolimus-Eluting Stent Restenosis ABSTRACT: Objective. The goal of this study was to determine the long-term clinical outcomes after an initial...
Longer-Term Outcomes of Paclitaxel Stent Implantation as an Initial Treatment Strategy for Sirolimus-Eluting Stent Restenosis ABSTRACT: Objective. The goal of this study was to determine the long-term clinical outcomes after an initial...
Longer-Term Outcomes of...
05/06/2010
Journal of Invasive Cardiology
Original Contribution
Progression of Coronary Artery Atherosclerosis After Acute Myocardial Infarction: An Angiographic Study
05/05/2010
Michal Hawranek, MD, Mariusz Gasior, PhD, Marek Gierlotka, MD, Krzysztof Wilczek, MD, Andrzej Lekston, PhD, Bozena Szygula-Jurkiewicz, MD, Artur Spatuszko, Lech Polonski, PhD
Michal Hawranek, MD, Mariusz Gasior,...
ABSTRACT: Aims. Today’s knowledge concerning the progression of coronary artery disease (CAD) is mainly derived from randomised clinical studies performed in patients with stable CAD. Data on atherosclerosis progression (AP) after myocardial...
ABSTRACT: Aims. Today’s knowledge concerning the progression of coronary artery disease (CAD) is mainly derived from randomised clinical studies performed in patients with stable CAD. Data on atherosclerosis progression (AP) after myocardial...
ABSTRACT: Aims. Today’s...
05/05/2010
Journal of Invasive Cardiology
Original Contribution
Transradial Approach to Subclavian Artery Stenting
05/05/2010
Jennie Yu, MD, Ravikiran Korabathina, MD, John Coppola, MD, Cezar Staniloae, MD
Jennie Yu, MD, Ravikiran Korabathina...
ABSTRACT: Background. Subclavian artery angioplasty has been traditionally performed via the transfemoral approach. Transradial access is becoming increasingly used for coronary as well as for certain peripheral vascular beds. We describe our...
ABSTRACT: Background. Subclavian artery angioplasty has been traditionally performed via the transfemoral approach. Transradial access is becoming increasingly used for coronary as well as for certain peripheral vascular beds. We describe our...
ABSTRACT: Background. Subclavian...
05/05/2010
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

May 2010 Volume 22 Issue 5

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement